High-dose influenza vaccine: enhanced protection for the elderly
Introduction Seasonal influenza causes up to 50 million symptomatic cases and 15,000 – 70,000 deaths annually within the European Union. While influenza affects all age groups, adults aged ≥65 years disproportionately experience high rates of influenza-related hospitalizations and complications. Vac...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2025-12-01
|
| シリーズ: | Expert Review of Vaccines |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2596673 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|